Stock analysis, AI verdict, fundamentals & technical signals
Rating: SELL
Price: $286.00 Analyst target: $283.19 Upside: -0.98%
AbbVie is an American publicly traded biopharmaceutical company founded in 2013. It originated as a spin-off of Abbott Laboratories.
See the full interactive analysis & chart →Informational only — not investment advice.